◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
MRKR: Marker Therapeutics Inc Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 170.18 |
| Enterprise Value ($M) | 154.59 |
| Book Value ($M) | 27.34 |
| Book Value / Share | 0.33 |
| Price / Book | 6.44 |
| NCAV ($M) | 6.14 |
| NCAV / Share | 0.07 |
| Price / NCAV | 28.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.05 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.65 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | 3.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 24.41 |
| Assets | 45.61 |
| Liabilities | 18.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -28.89 |
| Net Income | -28.71 |
| Earnings Per Share Basic And Diluted | -0.61 |
| Earnings Per Share Diluted | -0.61 |
| Earnings Per Share Basic | -0.61 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.86 |
| Cash from Investing | -10.43 |
| Cash from Financing | -10.43 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | New Enterprise Associates 16, L.P. | 17.40 | 65.31 | |
| 13D/A | Leen Ann M. | 2.89 | 0.00 | |
| 13D/A | Eastern Capital LTD | 5.00 | -11.19 | |
| 13G/A | Perceptive Advisors Llc | 0.00 | -100.00 | |
| 13D | Wilson John Robert | 17.37 | ||
| 13D | Vera Juan | 5.90 | ||
| 13G/A | Brio Capital Master Fund Ltd. | 0.05 | ||
| 13D | Aisling Capital IV, LP | 7.70 | ||
| 13D | Iroquois Capital Management, LLC | 7.30 | -4.14 | |
| 13G/A | American Capital Management LLC | 4.90 | 100.00 | |
| 13G/A | Empery Asset Management, LP | 4.99 | ||
| 13G/A | Tonaquint, Inc. | 9.99 | ||
| 13G/A | Centra Holdings, Inc. | 9.90 | ||
| 13D | Barchha Sailesh C. | 7.58 | ||
| 13D | Gardner Michael | 7.58 | ||
| 13G/A | Ironridge Global IV, Ltd. |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Annual Report – 10-K | ||
| Quarterly Report – FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 337,916 | 1,679,200 | 20.12 | |
| 209,652 | 1,198,706 | 17.49 | |
| 389,304 | 2,252,350 | 17.28 | |
| 141,943 | 1,159,695 | 12.24 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MOR – MorphoSys AG | MORF – Morphic Holding Inc |
| MREO – Mereo BioPharma Group plc | MRNA – Moderna Inc |
| MRNS – Marinus Pharmaceuticals Inc |
Financial data and stock pages provided by
Fintel.io
2018/07/06
